BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38656284)

  • 1. ALK-Positive Histiocytosis-A Distinct Histiocytic Entity Deserving Recognition.
    Kemps PG; Picarsic JL; Emile JF
    JAMA Dermatol; 2024 Apr; ():. PubMed ID: 38656284
    [No Abstract]   [Full Text] [Related]  

  • 2. ALK-Positive Histiocytosis-A Distinct Histiocytic Entity Deserving Recognition-Reply.
    Xu J; Yao X; Xu Z
    JAMA Dermatol; 2024 Apr; ():. PubMed ID: 38656502
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
    Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
    Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system involvement of systemic ALK-positive histiocytosis with
    Aoki Y; Maeda M; Kishi S; Kogue R; Tanaka F; Umino M; Takeoka M; Hanaki R; Hirayama J; Yuasa H; Imai H; Hirayama M; Sakuma H
    Radiol Case Rep; 2022 Oct; 17(10):3867-3870. PubMed ID: 35982724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
    Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
    Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases.
    Huang H; Gheorghe G; North PE; Suchi M
    Pediatr Dev Pathol; 2018; 21(5):449-455. PubMed ID: 29224419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by
    Li Y; Shi C; Wu Y; He M; Xia X; Liu J; Jiang Y
    Front Med (Lausanne); 2022; 9():840407. PubMed ID: 35665359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report.
    Tian Y; Li J; Liu B; Xie H; Zheng M; Yao W
    Ann Palliat Med; 2021 Sep; 10(9):10095-10101. PubMed ID: 34628929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
    Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
    Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.
    He Q; Zhang W; Li Q
    BMC Pediatr; 2022 May; 22(1):308. PubMed ID: 35614430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
    Zhou Y; Hurtado-Castillo M; Pandey O
    Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-Positive Histiocytosis: A Case Report and Literature Review.
    Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
    Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.
    Chan JK; Lamant L; Algar E; Delsol G; Tsang WY; Lee KC; Tiedemann K; Chow CW
    Blood; 2008 Oct; 112(7):2965-8. PubMed ID: 18660380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
    Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
    Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
    Wolter NE; Ngan B; Whitlock JA; Dickson BC; Propst EJ
    Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109585. PubMed ID: 31351348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.